Navigation Links
Agreement To Speed Up Development of Bird flu vaccine

In a collective effort to combat the bird flu pandemic, international health ministers have struck an agreement to speed up the development and production of a pandemic bird flu vaccine.

Ministers from the US, Canada, France, Germany, Japan, // Mexico, Italy, representatives of the World Health Organization (WHO) and the European Union (EU) health commissioners - all members of the Global Health Security Initiative (GHSI) - met in Rome to discuss the global threat from a bird flu pandemic and agreed to share 'information and expertise' to fast-track development of a vaccine more quickly and production and will make sure supplies meet demand.

UK health minister Rosie Winterton, who attended the conference with the representatives of eight other countries, said: 'We recognized the importance of ensuring our populations and healthcare professionals have the high quality, consistent international information they need to manage the consequences of an outbreak of pandemic flu.

Her comments came a matter of days after China confirmed the country's first case of bird flu in a human, whipping up fresh fears of a global pandemic. As the case was confirmed, the Chinese government announced it was to vaccinate all of the country's 14 billion poultry to stem the spread of the disease.

Avian flu has affected the Southeast Asian nations although it is largely limited to poultry and wild-bird populations.

Experts fear that the H5N1 virus is on the verge of undergoing mutation, thus making it easier to spread from birds to humans.

In the event of this happening the impact worldwide would be tremendous, experts say. And in the absence of a vaccine or drug against the bird flu, the loss of life would be unprecedented.

The leaders have also agreed to work together to boost global capacity for pandemic flu vaccine.
'"/>




Page: 1

Related medicine news :

1. MIOT Hospital Signs Agreement With German Healthcare Facility
2. Strained Economic Agreement Between Singapore And India
3. Ranbaxy Signs Agreement With Zenotech For Cancer Drugs
4. Subsidies For GPs Visits : Agreement Reached
5. Agreement for Joint Trials of Avian Flu Vac cine on Humans
6. Ranbaxy Signs Licensing, Supply Agreement for Canadian Market
7. Indo-Fiji Agreement in Field of Health, Medicine Approved
8. Publishers John Wiley & Sons Enter Into An Agreement With NASPGHAN And AASLD
9. Medical Training Must Be Core Component Of Health Care Agreements
10. High Altitude ‘Speeds up ageing process
11. Speed up bird flu vaccine, Bush tells experts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... ... , ... IndustryArchive.Org . is announcing a new way for B2B Sellers ... only pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase ... reality that B2B buyers are controlling the sales process via the Internet and that ...
(Date:2/26/2017)... ... , ... ODH, Inc.™ announced today it will exhibit and speak at ... Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present ... population health management. , ODH will also have an exhibit booth where attendees may ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... its newly designed TaskMate Go. Core benefits and advantages built into the home ... a stylish, functional look and feel. Ability to gain the benefits embedded in ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the ... Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run of ... book measures almost a metre across when open, weighs in at more than six ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
(Date:2/24/2017)... Wyoming , Feb. 24, 2017  Xynomic Pharmaceuticals, ... today announced that it has acquired exclusive worldwide ... potentially best-in-class innovative HDAC inhibitor targeting hematological and ... of 14 Phase 1 and 2 clinical trials ... Asia have already been completed, demonstrating ...
Breaking Medicine Technology: